These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35973341)

  • 21. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
    Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
    [No Abstract]   [Full Text] [Related]  

  • 22. Supervised consumption sites: a nuanced assessment of the causal evidence.
    Caulkins JP; Pardo B; Kilmer B
    Addiction; 2019 Dec; 114(12):2109-2115. PubMed ID: 31309637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.
    Park JN; Sherman SG; Rouhani S; Morales KB; McKenzie M; Allen ST; Marshall BDL; Green TC
    J Urban Health; 2019 Jun; 96(3):353-366. PubMed ID: 31168735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing opioid overdose hotspots for place-based overdose prevention and treatment interventions: A geo-spatial analysis of Rhode Island, USA.
    Samuels EA; Goedel WC; Jent V; Conkey L; Hallowell BD; Karim S; Koziol J; Becker S; Yorlets RR; Merchant R; Keeler LA; Reddy N; McDonald J; Alexander-Scott N; Cerda M; Marshall BDL
    Int J Drug Policy; 2024 Mar; 125():104322. PubMed ID: 38245914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing Use of Supervised Consumption Services among Street-involved Youth and Young Adults in the Context of an Overdose Crisis.
    Lee-Pii K; DeBeck K; Choi J; Sedgemore KO; Kerr T; Kennedy MC
    J Urban Health; 2024 Apr; 101(2):233-244. PubMed ID: 38536600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between willingness to use an overdose prevention center and probation or parole status among people who use drugs in Rhode Island.
    Tan M; Park C; Goldman J; Biello KB; Buxton J; Hadland SE; Park JN; Sherman SG; Macmadu A; Marshall BDL
    Harm Reduct J; 2024 Feb; 21(1):54. PubMed ID: 38424553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
    Bardwell G; Collins AB; McNeil R; Boyd J
    Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demographic, geographic, and temporal patterns of ambulance runs for suspected opiate overdose in Rhode Island, 1997-20021.
    Merchant RC; Schwartzapfel BL; Wolf FA; Li W; Carlson L; Rich JD
    Subst Use Misuse; 2006; 41(9):1209-26. PubMed ID: 16861173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trial.
    Marshall BDL; Alexander-Scott N; Yedinak JL; Hallowell BD; Goedel WC; Allen B; Schell RC; Li Y; Krieger MS; Pratty C; Ahern J; Neill DB; Cerdá M
    Addiction; 2022 Apr; 117(4):1152-1162. PubMed ID: 34729851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced Emergency Department Visits and Hospitalisation with Use of an Unsanctioned Safe Consumption Site for Injection Drug Use in the United States.
    Lambdin BH; Davidson PJ; Browne EN; Suen LW; Wenger LD; Kral AH
    J Gen Intern Med; 2022 Nov; 37(15):3853-3860. PubMed ID: 35020166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State Unintentional Drug Overdose Reporting Surveillance: Opioid Overdose Deaths and Characteristics in Rhode Island.
    Jiang Y; McDonald JV; Goldschmidt A; Koziol J; McCormick M; Viner-Brown S; Alexander-Scott N
    R I Med J (2013); 2018 Sep; 101(7):25-30. PubMed ID: 30189700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
    Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
    Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study.
    Uyei J; Fiellin DA; Buchelli M; Rodriguez-Santana R; Braithwaite RS
    Lancet Public Health; 2017 Mar; 2(3):e133-e140. PubMed ID: 29253386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs.
    Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF
    Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital.
    Nolan S; Kelian S; Kerr T; Young S; Malmgren I; Ghafari C; Harrison S; Wood E; Lysyshyn M; Holliday E
    Drug Alcohol Depend; 2022 Oct; 239():109608. PubMed ID: 36063622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis.
    Rammohan I; Gaines T; Scheim A; Bayoumi A; Werb D
    Lancet Public Health; 2024 Feb; 9(2):e79-e87. PubMed ID: 38307685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States.
    Townsend T; Blostein F; Doan T; Madson-Olson S; Galecki P; Hutton DW
    Int J Drug Policy; 2020 Jan; 75():102536. PubMed ID: 31439388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.
    Bernard CL; Rao IJ; Robison KK; Brandeau ML
    PLoS Med; 2020 Oct; 17(10):e1003239. PubMed ID: 33048929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.